162 related articles for article (PubMed ID: 16483184)
1. Teratogenicity with angiotensin II receptor antagonists in pregnancy.
Boix E; Zapater P; Picó A; Moreno O
J Endocrinol Invest; 2005 Dec; 28(11):1029-31. PubMed ID: 16483184
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
Schaefer C
Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blockers in pregnancy: a report of five cases.
Gersak K; Cvijic M; Cerar LK
Reprod Toxicol; 2009 Jul; 28(1):109-12. PubMed ID: 19491003
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature.
Velázquez-Armenta EY; Han JY; Choi JS; Yang KM; Nava-Ocampo AA
Hypertens Pregnancy; 2007; 26(1):51-66. PubMed ID: 17454218
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome.
Haaland K
J Headache Pain; 2010 Apr; 11(2):167-9. PubMed ID: 20063032
[TBL] [Abstract][Full Text] [Related]
6. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
7. Acute pancreatitis associated with irbesartan therapy.
Famularo G; Minisola G; Nicotra GC; De Simone C
Pancreas; 2005 Oct; 31(3):294-5. PubMed ID: 16163066
[No Abstract] [Full Text] [Related]
8. Severe anemia caused by the angiotensin receptor blocker irbesartan after renal transplantation.
Simonetti GD; Bianchetti MG; Konrad M; von Vigier RO
Pediatr Nephrol; 2007 May; 22(5):756-7. PubMed ID: 17216246
[No Abstract] [Full Text] [Related]
9. Could irbesartan trigger autoimmune cholestatic hepatitis?
Annicchiarico BE; Siciliano M
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):247-8. PubMed ID: 15674105
[No Abstract] [Full Text] [Related]
10. [Leukoneutropenia associated with irbesartan].
Gómez-Sayago L; Queizán Hernández JA; García-López L; Criado Illana MT
Farm Hosp; 2012; 36(4):302-3. PubMed ID: 22129651
[No Abstract] [Full Text] [Related]
11. Penile angioedema associated with the use of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers.
McCabe J; Stork C; Mailloux D; Su M
Am J Health Syst Pharm; 2008 Mar; 65(5):420-1. PubMed ID: 18281733
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo.
Meijer P; Wouters CW; Oyen WJ; Boerman OC; Scheffer GJ; Smits P; Rongen GA
J Cardiovasc Pharmacol; 2011 Jun; 57(6):702-6. PubMed ID: 21423028
[TBL] [Abstract][Full Text] [Related]
13. Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected.
Kato K; Okuda M; Ishikawa H; Takahashi T; Hirahara F
J Obstet Gynaecol Res; 2008 Apr; 34(2):242-6. PubMed ID: 18412789
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor antagonist treatment during pregnancy.
Alwan S; Polifka JE; Friedman JM
Birth Defects Res A Clin Mol Teratol; 2005 Feb; 73(2):123-30. PubMed ID: 15669052
[TBL] [Abstract][Full Text] [Related]
17. [Cross reactivity between ACE inhibitors and angiotensin receptor blockers].
Rosenborg S
Lakartidningen; 2010 Feb 17-23; 107(7):444. PubMed ID: 20384078
[No Abstract] [Full Text] [Related]
18. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
[TBL] [Abstract][Full Text] [Related]
19. Systemic illness with skin eruption, fever and positive lymphocyte transformation test in a patient on irbesartan.
Constable S; Farrell J; Naisbitt D; King C; Leonard N; Pirmohamed M
Br J Dermatol; 2006 Aug; 155(2):491-3. PubMed ID: 16882204
[No Abstract] [Full Text] [Related]
20. Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists.
Sinelli MT; Cattarelli D; Cortinovis S; Maroccolo D; Chirico G
Pediatr Med Chir; 2008; 30(6):306-8. PubMed ID: 19431954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
